MétaCan
Menu
Back to cohort

Abstract P6-05-02: Expression of ING1b-derived peptide inhibits viability of breast cancer cells and promotes apoptosis

2015· article· en· W1631305180 on OpenAlexaff
Oleksandr Boyko, Karl Riabowol

Bibliographic record

VenueCancer Research · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicProtein Degradation and Inhibitors
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsApoptosisCancer researchNLSNuclear localization sequenceBiologyMolecular biologyCancer cellChromatinCell biologyCancerGeneBiochemistryGenetics

Abstract

fetched live from OpenAlex

Abstract The ING1b protein is a type II tumor suppressor and a stoichiometric member of HDAC-containing protein complexes. Primarily by altering chromatin structure, ING1b contributes to regulation of gene expression, senescence and apoptosis. Mislocalization and decreased levels of ING1b are commonly observed in human tumors and cancer cell lines. Multiple independent studies in varied cell types report that ING1b overexpression promotes apoptosis. Since the inactivation of apoptosis pathways is frequent in cancer cells, modulating ING1b expression in tumors may serve as a viable approach for cancer therapy. We have defined the minimal ING1b region that confers apoptotic function as estimated by the levels of PARP cleavage, FACS analysis and using an Annexin V binding assay. We have established that ING1b-derived peptides containing its third alpha helix (A3H) and NLS/NTS domains are able to induce apoptosis at levels comparable to those of full length ING1b. The A3H-NLS/NTS peptide exhibited strong nucleolar localization characteristic of full length ING1b. Cells overexpressing the full length ING1b and A3H-NLS/NTS peptide showed similar changes in cell morphology characteristic of apoptosis and exhibited increased levels of PARP cleavage. While the A3H region that includes the N-terminal part of the highly conserved Lamin Interacting Domain (LID) was necessary but not sufficient, the NLS/NTS domain that mediates nuclear and nucleolar localization of ING1b was required and partially sufficient for induction of apoptosis. Adenoviral-mediated expression of A3H-NLS/NTS peptide in cells of osteosarcoma, glioblastoma and breast cancer origins resulted in strong reduction of cell viability. Depending on the cell line, treating cells with 45 MOI of virus expressing A3H-NLS/NTS peptide resulted in a 60 - 85% decrease in cancer cell survival compared to cells treated with the control construct (Ad-GFP), and the highly transformed triple negative tumorigenic MDA-MB-468 breast cancer line was sensitive to the peptide when infected with 5 MOI of A3H-NLS/NTS adenovirus. These pro-apoptotic effects were found to be dose and time dependent. Furthermore, using p53 wild-type, p53 mutant and p53-null cancer cell lines we demonstrated that the effects of A3H-NLS/NTS expression on cell survival and apoptosis were independent of p53-status. The evaluation of the synergy between the A3H-NLS/NTS peptide and common chemotherapeutic agents is currently ongoing. Our long-term goal is to develop ING1b-based therapeutics that can be used as an adjuvant therapy in combination with the existing breast cancer treatments. Citation Format: Oleksandr Boyko, Karl Riabowol. Expression of ING1b-derived peptide inhibits viability of breast cancer cells and promotes apoptosis [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P6-05-02.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.049
GPT teacher head0.351
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicProtein Degradation and InhibitorsFrench-language works237,207